Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT00005638
- Phase
- PHASE1
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUG
- irinotecan hydrochloride — DRUG
- radiation therapy — RADIATION
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy plus radiation therapy in treating patients who have advanced cancer of the esophagus.
Key Dates
- Start date
- Oct 31, 1999
- Status verified
- Jun 2013
- Primary completion
- Apr 30, 2004
- Completion
- Apr 30, 2004
Study Design
- Primary purpose
- TREATMENT
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| USC/Norris Comprehensive Cancer Center and Hospital | Los Angeles | California | 90033-0804 | - |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | - |
Find similar trials in Los Angeles, CA
By condition
By specialty
Related Studies
- Clinical & Pathological Studies of Upper Gastrointestinal CarcinomaRecruiting · Stanford University · Stanford, California
- The Gastric Cancer Foundation: A Gastric Cancer RegistryRecruiting · Stanford University · Stanford, California
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)Recruiting · University of Colorado, Denver · Los Angeles, California